Details for 2015834774
Up to date per 02.04.2026
Actions
Details for 2015834774
Granted/Registered
European Patent
01.11.2017 A
25.01.2023 B1
24.12.2014
US
201462096812 P
A61K 9/00 20060101AFI20220627BHEP
Owner
Principia Biopharma Inc.220 E. Grand Ave. S. San Francisco, CA 94080US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
NUNN, Philip, A.242 Mountain View Avenue Mountain View CA 94041US
BERNER, Bret424 Lee Ave Half Moon Bay CA 94019US
MASJEDIZADEH, Mohammad, Reza5341 Elrose Avenue San Jose CA 95124US
Information about Fees